Cargando…
Liver transplant outcomes during the COVID-19 pandemic
Autores principales: | Mendizabal, Manuel, Pages, Josefina, Piñero, Federico, Thompson, Marcos, Silva, Marcelo O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695317/ https://www.ncbi.nlm.nih.gov/pubmed/34954071 http://dx.doi.org/10.1016/j.aohep.2021.100656 |
Ejemplares similares
-
P-101 IMPACT OF COMPLETE AND PREVENTIVE LOCKED–DOWN BEFORE COVID 19 OUTBREAK IN ORGAN PROCUREMENT AND SOLID TRANSPLANTATION IN ARGENTINA: THE WORST HAS NOT YET ARRIVED.
por: Pages, Josefina, et al.
Publicado: (2021) -
Lenvatinib as first-line therapy for recurrent hepatocellular carcinoma after liver transplantation: Is the current evidence applicable to these patients?
por: Piñero, Federico, et al.
Publicado: (2020) -
ABO incompatible living donor related liver transplant in COVID-19 pandemic: Challenges and outcomes
por: Jadaun, Shekhar Singh, et al.
Publicado: (2022) -
Letter to the Editor: Living Donor Liver Transplantation During the COVID-19 Pandemic: An Evolving Challenge
por: Muhammad, Haris, et al.
Publicado: (2021) -
Successful urgent liver transplant due to fulminant autoimmune hepatitis during the height of the COVID-19 pandemic in Spain()
por: Rodríguez-Gandía, Miguel A., et al.
Publicado: (2020)